JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.14% |
| 2 | Technology | 13.12% |
| 3 | Financials | 12.1% |
| 4 | Healthcare | 9.54% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
PNC Financial Services
PNC
$87.1B
| $2.01B | 0.38% |
12,602,155
+683,301
| +6% | +$103M |
2013 Q2
26 quarters
|
|
52
CALL
iShares S&P 100 ETF
OEF
$20.8B
| $1.95B | 0.36% |
26,105,900
-12,685,500
| -33% | -$1.74B |
2014 Q3
21 quarters
|
|
53
Vanguard S&P 500 ETF
VOO
$1.06T
| $1.93B | 0.36% |
6,525,129
-210,806
| -3% | -$59.6M |
2013 Q2
26 quarters
|
|
|
54
PUT
iShares S&P 100 ETF
OEF
$20.8B
| $1.92B | 0.36% |
24,316,000
-17,642,100
| -42% | -$2.42B |
2013 Q2
26 quarters
|
|
55
Automatic Data Processing
ADP
$108B
| $1.84B | 0.34% |
10,794,268
-40,612
| -0.4% | -$6.72M |
2013 Q2
26 quarters
|
|
56
RTX Corp
RTX
$249B
| $1.84B | 0.34% |
19,511,491
+1,820,498
| +10% | +$165M |
2013 Q2
26 quarters
|
|
57
Boston Scientific
BSX
$61.5B
| $1.81B | 0.34% |
40,056,004
-2,254,655
| -5% | -$94.3M |
2013 Q2
26 quarters
|
|
58
Charter Communications
CHTR
$12.2B
| $1.79B | 0.33% |
3,689,852
-705,285
| -16% | -$325M |
2013 Q2
26 quarters
|
|
59
Prologis
PLD
$123B
| $1.78B | 0.33% |
19,962,504
-2,481,865
| -11% | -$220M |
2013 Q2
26 quarters
|
|
60
Philip Morris
PM
$312B
| $1.76B | 0.33% |
20,732,856
+4,153,725
| +25% | +$342M |
2013 Q2
26 quarters
|
|
61
PepsiCo
PEP
$171B
| $1.76B | 0.33% |
12,892,291
+1,559,365
| +14% | +$212M |
2013 Q2
26 quarters
|
|
62
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.74B | 0.33% |
7,703,322
+1,623,392
| +27% | +$353M |
2013 Q2
26 quarters
|
|
|
63
Truist Financial
TFC
$56B
| $1.73B | 0.32% |
30,783,949
+17,800,957
| +137% | +$964M |
2013 Q2
26 quarters
|
|
64
Thermo Fisher Scientific
TMO
$243B
| $1.72B | 0.32% |
5,279,954
-377,442
| -7% | -$114M |
2013 Q2
26 quarters
|
|
65
Cigna
CI
$75.1B
| $1.7B | 0.32% |
8,332,835
-1,079,870
| -11% | -$198M |
2013 Q2
26 quarters
|
|
66
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $1.68B | 0.31% |
13,377,468
+2,326,595
| +21% | +$294M |
2013 Q2
26 quarters
|
|
67
ConocoPhillips
COP
$162B
| $1.67B | 0.31% |
25,607,782
+3,056,548
| +14% | +$180M |
2013 Q2
26 quarters
|
|
68
iShares Core US Aggregate Bond ETF
AGG
$136B
| $1.64B | 0.31% |
14,594,628
+406,579
| +3% | +$45.8M |
2013 Q2
26 quarters
|
|
69
O'Reilly Automotive
ORLY
$69.7B
| $1.6B | 0.3% |
54,808,785
-4,586,190
| -8% | -$131M |
2013 Q2
26 quarters
|
|
70
iShares MSCI Japan ETF
EWJ
$23.9B
| $1.6B | 0.3% |
27,002,592
+421,860
| +2% | +$24.9M |
2013 Q2
26 quarters
|
|
71
AbbVie
ABBV
$485B
| $1.59B | 0.3% |
17,954,007
+4,527,315
| +34% | +$376M |
2013 Q2
26 quarters
|
|
72
NVIDIA
NVDA
$5.58T
| $1.56B | 0.29% |
264,347,080
-41,577,720
| -14% | -$216M |
2013 Q2
26 quarters
|
|
73
Netflix
NFLX
$299B
| $1.54B | 0.29% |
47,472,880
-21,750,800
| -31% | -$645M |
2013 Q2
26 quarters
|
|
74
Medtronic
MDT
$114B
| $1.53B | 0.29% |
13,511,287
+2,542,843
| +23% | +$279M |
2013 Q2
26 quarters
|
|
75
General Dynamics
GD
$89.2B
| $1.51B | 0.28% |
8,552,260
-1,386,826
| -14% | -$249M |
2013 Q2
26 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.